Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Lazertinib

b3bff9f6-0d8e-5f55-8820-7ec57691547b · FDA Approved · targets EGFR

Lazertinib

MeasuredReference

Lazertinib targets EGFR, ERBB2_HER2, BLK.

Primary targets

EGFRERBB2_HER2BLKERBB4_HER4JAK3

Top hallmarks

No hallmark data.

Top pathways disrupted

No pathway data.

Resistance landscape — Lazertinib

MeasuredReference

10 known oncogenic variants exist on Lazertinib's top targets — see detail for inhibition impact.

Open in new tab